Notably, in patients with both low serum and low BALF CHI3L1 levels, no IPF related mortality was observed, suggesting that serum CHI3L1 could be a useful prognostic marker (Korthagen et al., 2011). Here, CHI3L1 is linked to idiopathic pulmonary fibrosis.